Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Ovarian Neoplasms

  Free Subscription


Articles published in Am J Obstet Gynecol

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    March 2010
  1. HERZOG TJ , Krivak TC, Fader AN, Coleman RL, et al
    Chemosensitivity testing with ChemoFx and overall survival in primary ovarian cancer.
    Am J Obstet Gynecol. 2010.
    PubMed     Text format     Related articles    Abstract available


  2. COOK LS , Neilson HK, Lorenzetti DL, Lee RC, et al
    A systematic literature review of vitamin D and ovarian cancer.
    Am J Obstet Gynecol. 2010.
    PubMed     Text format     Related articles    Abstract available


    February 2010
  3. LOAR P , Wahl H, Kshirsagar M, Gossner G, et al
    Inhibition of glycolysis enhances cisplatin-induced apoptosis in ovarian cancer cells.
    Am J Obstet Gynecol. 2010.
    PubMed     Text format     Related articles    Abstract available


  4. CHEREAU E , Ballester M, Selle F, Cortez A, et al
    Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer.
    Am J Obstet Gynecol. 2010;202:178.
    PubMed     Text format     Related articles    Abstract available


  5. BEN-AMI I , Smorgick N, Tovbin J, Fuchs N, et al
    Does intraoperative spillage of benign ovarian mucinous cystadenoma increase its recurrence rate?
    Am J Obstet Gynecol. 2010;202:142.
    PubMed     Text format     Related articles    Abstract available


    October 2009
  6. TANBAKUCHI AA , Udovich JA, Rouse AR, Hatch KD, et al
    In vivo imaging of ovarian tissue using a novel confocal microlaparoscope.
    Am J Obstet Gynecol. 2009.
    PubMed     Text format     Related articles    Abstract available


  7. RAFII A , Camicas A, Ferron G, Mery E, et al
    A comparative study of laparoscopic extraperitoneal lymphadenectomy [correction of laparoscopy] with the use of ultrasonically activated shears.
    Am J Obstet Gynecol. 2009;201:370.
    PubMed     Text format     Related articles    Abstract available


    September 2009
  8. IDAHL A , Lundin E, Elgh F, Jurstrand M, et al
    Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions.
    Am J Obstet Gynecol. 2009.
    PubMed     Text format     Related articles    Abstract available


    August 2009
  9. HELPMAN L , Katz BZ, Safra T, Schreiber L, et al
    Systematic antigenic profiling of hematopoietic antigens on ovarian carcinoma cells identifies membrane proteins for targeted therapy development.
    Am J Obstet Gynecol. 2009;201:196.
    PubMed     Text format     Related articles    Abstract available


    July 2009
  10. ZHENG H , Hu W, Deavers MT, Shen DY, et al
    Nuclear cyclin B1 is overexpressed in low-malignant-potential ovarian tumors but not in epithelial ovarian cancer.
    Am J Obstet Gynecol. 2009.
    PubMed     Text format     Related articles    Abstract available


  11. BLANK SV
    Cookie cutter doesn't cut it.
    Am J Obstet Gynecol. 2009;201:e17.
    PubMed     Text format     Related articles   


    June 2009
  12. MASSAD LS , Parks L, Rimel BJ, Kizer N, et al
    Discussion: 'Biomarkers for detection of early ovarian cancer' by Nosov et al.
    Am J Obstet Gynecol. 2009;200:e1-3.
    PubMed     Text format     Related articles   


    May 2009
  13. ROMANI C , Comper F, Bandiera E, Ravaggi A, et al
    Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas.
    Am J Obstet Gynecol. 2009.
    PubMed     Text format     Related articles    Abstract available


    April 2009
  14. DUNTON CJ , Carp N
    Unexpected finding in a pelvic mass Imaging suggested an ovarian malignancy.
    Am J Obstet Gynecol. 2009.
    PubMed     Text format     Related articles   


    March 2009
  15. NOSOV V , Su F, Amneus M, Birrer M, et al
    Validation of serum biomarkers for detection of early-stage ovarian cancer.
    Am J Obstet Gynecol. 2009.
    PubMed     Text format     Related articles    Abstract available


  16. SHARMA A , Belna J, Espat J, Rodriguez G, et al
    Effects of omega-3 fatty acids on components of the transforming growth factor beta-1 pathway: implication for dietary modification and prevention in ovarian cancer.
    Am J Obstet Gynecol. 2009.
    PubMed     Text format     Related articles    Abstract available


  17. SMORGICK N , Barel O, Halperin R, Schneider D, et al
    Laparoscopic removal of adnexal cysts: is it possible to decrease inadvertent intraoperative rupture rate?
    Am J Obstet Gynecol. 2009;200:237.
    PubMed     Text format     Related articles    Abstract available


    January 2009
  18. CHEREAU E , Stefanescu D, Selle F, Rouzier R, et al
    Spontaneous rectovaginal fistula during bevacizumab therapy for ovarian cancer: a case report.
    Am J Obstet Gynecol. 2009;200:e15-6.
    PubMed     Text format     Related articles    Abstract available


    December 2008
  19. LI Y , Hu W, Shen DY, Kavanagh JJ, et al
    Azacitidine enhances sensitivity of platinum-resistant ovarian cancer cells to carboplatin through induction of apoptosis.
    Am J Obstet Gynecol. 2008.
    PubMed     Text format     Related articles    Abstract available


    November 2008
  20. NEZHAT FR , Ezzati M, Chuang L, Shamshirsaz AA, et al
    Laparoscopic management of early ovarian and fallopian tube cancers: surgical and survival outcome.
    Am J Obstet Gynecol. 2008.
    PubMed     Text format     Related articles    Abstract available


  21. BULL PHELPS SL , Carbon J, Miller A, Castro-Rivera E, et al
    Secreted protein acidic and rich in cysteine as a regulator of murine ovarian cancer growth and chemosensitivity.
    Am J Obstet Gynecol. 2008.
    PubMed     Text format     Related articles    Abstract available


    October 2008
  22. BELLONE S , Anfossi S, O'Brien TJ, Cannon MJ, et al
    Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
    Am J Obstet Gynecol. 2008.
    PubMed     Text format     Related articles    Abstract available


  23. STEINBAKK A , Skaland I, Gudlaugsson E, Janssen EA, et al
    The prognostic value of molecular biomarkers in tissue removed by curettage from FIGO stage 1 and 2 endometrioid type endometrial cancer.
    Am J Obstet Gynecol. 2008.
    PubMed     Text format     Related articles    Abstract available


    September 2008
  24. CALDERON-MARGALIT R , Friedlander Y, Yanetz R, Deutsch L, et al
    Preeclampsia and subsequent risk of cancer: update from the Jerusalem Perinatal Study.
    Am J Obstet Gynecol. 2008.
    PubMed     Text format     Related articles    Abstract available


  25. FAGOTTI A , Ferrandina G, Fanfani F, Garganese G, et al
    Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma.
    Am J Obstet Gynecol. 2008.
    PubMed     Text format     Related articles    Abstract available


    August 2008
  26. LAVIE O , Gruber SB, Lejbkowicz F, Dishon S, et al
    Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation.
    Am J Obstet Gynecol. 2008;199:148.
    PubMed     Text format     Related articles    Abstract available


    June 2008
  27. ODEGAARD E , Davidson B, Engh V, Onsrud M, et al
    Assessment of endoglin and calprotectin as potential biomarkers in ovarian carcinoma and borderline tumors of the ovary.
    Am J Obstet Gynecol. 2008;.
    PubMed     Text format     Related articles    Abstract available


    May 2008
  28. LACHANCE JA , Shutter J, Atkins KA, Stoler MH, et al
    Utilization of a uniform grading system for interpreting serous ovarian cancer.
    Am J Obstet Gynecol. 2008;.
    PubMed     Text format     Related articles    Abstract available


  29. CHECHIA A , Attia L, Temime RB, Makhlouf T, et al
    Incidence, clinical analysis, and management of ovarian fibromas and fibrothecomas.
    Am J Obstet Gynecol. 2008;.
    PubMed     Text format     Related articles    Abstract available


  30. BRUN JL , Cortez A, Rouzier R, Callard P, et al
    Factors influencing the use and accuracy of frozen section diagnosis of epithelial ovarian tumors.
    Am J Obstet Gynecol. 2008;.
    PubMed     Text format     Related articles    Abstract available


  31. NOSSOV V , Amneus M, Su F, Lang J, et al
    The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
    Am J Obstet Gynecol. 2008;.
    PubMed     Text format     Related articles    Abstract available


    April 2008
  32. LU C , Thaker PH, Lin YG, Spannuth W, et al
    Impact of vessel maturation on antiangiogenic therapy in ovarian cancer.
    Am J Obstet Gynecol. 2008;198:477.
    PubMed     Text format     Related articles    Abstract available


  33. PLAXE SC
    Epidemiology of low-grade serous ovarian cancer.
    Am J Obstet Gynecol. 2008;198:459.
    PubMed     Text format     Related articles    Abstract available


  34. KURMAN RJ , Visvanathan K, Roden R, Wu TC, et al
    Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis.
    Am J Obstet Gynecol. 2008;198:351-6.
    PubMed     Text format     Related articles    Abstract available


  35. ABU-RUSTUM NR , Iasonos A, Zhou Q, Oke E, et al
    Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?
    Am J Obstet Gynecol. 2008;198:457.
    PubMed     Text format     Related articles    Abstract available


  36. BURGER RA
    A new model of ovarian carcinogenesis may influence early detection strategies.
    Am J Obstet Gynecol. 2008;198:349-50.
    PubMed     Text format     Related articles   


  37. YEN CF , Lee CL, Murk W, Han CM, et al
    Reducing peritoneal vascular endothelial growth factor concentration and inhibiting cancer scattering in a mouse model of laparoscopy.
    Am J Obstet Gynecol. 2008;198:423.
    PubMed     Text format     Related articles    Abstract available


    February 2008
  38. UEDA SM , Kapp DS, Cheung MK, Shin JY, et al
    Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths.
    Am J Obstet Gynecol. 2008;198:218.
    PubMed     Text format     Related articles    Abstract available


  39. CHAN JK , Kapp DS, Cheung MK, Shin JY, et al
    Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer.
    Am J Obstet Gynecol. 2008;198:216.
    PubMed     Text format     Related articles    Abstract available


  40. EISENHAUER EL , Sonoda Y, Levine DA, Abu-Rustum NR, et al
    Platinum resistance and impaired survival in patients with advanced primary peritoneal carcinoma: matched-case comparison with patients with epithelial ovarian carcinoma.
    Am J Obstet Gynecol. 2008;198:213.
    PubMed     Text format     Related articles    Abstract available


    January 2008
  41. ODEGAARD E , Davidson B, Elgaaen BV, Fagerhol MK, et al
    Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary.
    Am J Obstet Gynecol. 2008;.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: